Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$1.99 - $2.9 $65,315 - $95,183
-32,822 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$1.88 - $2.84 $35,392 - $53,465
-18,826 Reduced 36.45%
32,822 $71,000
Q3 2020

Nov 16, 2020

BUY
$2.69 - $4.95 $90,244 - $166,062
33,548 Added 185.35%
51,648 $139,000
Q2 2020

Aug 14, 2020

BUY
$0.7 - $4.16 $12,670 - $75,296
18,100 New
18,100 $71,000

Others Institutions Holding NAVB

About NAVIDEA BIOPHARMACEUTICALS, INC.


  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.